Clinical Trials Directory

Trials / Sponsors / Vicore Pharma AB

Vicore Pharma AB

Industry · 11 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Idiopathic Pulmonary Fibrosis (IPF)
Phase 22024-12-09
CompletedA Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes
Type2diabetes, Endothelial Dysfunction
Phase 12023-03-31
CompletedA Trial to Evaluate the Impact of C21 on the Exposure of 4 Substrates in Healthy Volunteers
Drug Interaction
Phase 12023-03-29
CompletedFirst-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects
Safety Issues, Tolerance, Idiopathic Pulmonary Fibrosis
Phase 12022-06-08
CompletedEffect of C21 on Forearm Blood Flow
Study Vasodilatory Effects of C21
Phase 12022-04-28
CompletedControlled Investigation to Evaluate Impact of dCBT on Psychological Symptom Burden in Adult Subjects With PF
Pulmonary Fibrosis, Anxiety
N/A2022-04-17
CompletedA Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects
COVID-19
Phase 32021-09-16
CompletedRetrospective Evaluation of Lung Pathology in Subjects With COVID-19
COVID-19, COVID-19 Pneumonia
—2021-07-07
CompletedSafety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF
Idiopathic Pulmonary Fibrosis
Phase 22020-11-13
CompletedSafety and Efficacy of C21 in Subjects With COVID-19
COVID-19
Phase 22020-07-21
CompletedCold Challenge With C21 in RP
Raynaud Phenomenon, Systemic Sclerosis
Phase 22020-01-03